OCM
AMGN icon

Oakwood Capital Management’s Amgen AMGN Stock Holding History

Oakwood Capital Management’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$6.8M Sell
27,901
-234
-0.8% -$57.6K 1.75% 22
2021
Q1 		$7M Sell
28,135
-40
-0.1% -$9.54K 2.06% 20
2020
Q4 		$6.48M Sell
28,175
-362
-1% -$83.5K 1.98% 20
2020
Q3 		$7.25M Sell
28,537
-418
-1% -$104K 2.68% 11
2020
Q2 		$6.83M Buy
28,955
+975
+3% +$222K 2.84% 10
2020
Q1 		$5.67M Sell
27,980
-675
-2% -$147K 3% 10
2019
Q4 		$6.91M Sell
28,655
-749
-3% -$165K 2.87% 13
2019
Q3 		$5.69M Sell
29,404
-672
-2% -$129K 2.52% 18
2019
Q2 		$5.54M Buy
30,076
+145
+0.5% +$26K 2.38% 22
2019
Q1 		$5.69M Sell
29,931
-565
-2% -$108K 2.39% 19
2018
Q4 		$5.94M Buy
30,496
+5
+0% +$975 2.78% 13
2018
Q3 		$6.32M Sell
30,491
-383
-1% -$75.5K 2.56% 16
2018
Q2 		$5.7M Sell
30,874
-715
-2% -$126K 2.4% 18
2018
Q1 		$5.38M Sell
31,589
-90
-0.3% -$16.5K 2.3% 21
2017
Q4 		$5.51M Sell
31,679
-55
-0.2% -$9.73K 1.22% 35
2017
Q3 		$5.92M Sell
31,734
-620
-2% -$110K 1.38% 24
2017
Q2 		$5.57M Sell
32,354
-1,275
-4% -$207K 1.37% 23
2017
Q1 		$5.52M Sell
33,629
-155
-0.5% -$25.8K 1.37% 26
2016
Q4 		$4.94M Sell
33,784
-779
-2% -$117K 1.26% 28
2016
Q3 		$5.76M Sell
34,563
-463
-1% -$78.3K 1.48% 28
2016
Q2 		$5.33M Sell
35,026
-252
-0.7% -$39.2K 1.39% 33
2016
Q1 		$5.29M Buy
35,278
+780
+2% +$116K 1.4% 32
2015
Q4 		$5.6M Buy
34,498
+305
+0.9% +$47.9K 1.51% 28
2015
Q3 		$4.73M Buy
34,193
+1,940
+6% +$306K 1.32% 36
2015
Q2 		$4.95M Buy
32,253
+1,012
+3% +$162K 1.29% 36
2015
Q1 		$4.99M Sell
31,241
-9,181
-23% -$1.45M 1.37% 30
2014
Q4 		$6.44M Buy
40,422
+735
+2% +$115K 1.83% 14
2014
Q3 		$5.57M Buy
39,687
+1,132
+3% +$148K 1.62% 17
2014
Q2 		$4.56M Buy
+38,555
New +$4.46M 1.37% 28

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Oakwood Capital Management's AMGN Position: Q2 2021 in Review

Oakwood Capital Management reduced its Amgen (AMGN) stake by 0.83% in Q2 2021, selling an estimated $57.6K and leaving 27,901 shares worth $6.8M. The position accounts for 1.75% of the portfolio, ranked #22.

Oakwood Capital Management first reported a position in AMGN in Q2 2014 and has held it in 29 quarters since. The position peaked at $7.25M in Q3 2020. 2,194 funds tracked by Wall St. Rank hold AMGN as of Q2 2021.

  • Oakwood Capital Management held 27,901 shares of Amgen worth $6.8M as of Q2 2021.
  • Oakwood Capital Management sold 234 Amgen shares in Q2 2021, an estimated $57.6K.
  • Amgen made up 1.75% of Oakwood Capital Management's portfolio in Q2 2021, its #22 holding.
  • Oakwood Capital Management first reported a position in Amgen in Q2 2014 and has held it in 29 quarters since.
  • Oakwood Capital Management's Amgen position peaked at $7.25M in Q3 2020.
  • 2,194 funds tracked by Wall St. Rank held Amgen as of Q2 2021.

Based on Oakwood Capital Management's 13F filing for Q2 2021, filed 22 Jul 2021.